Awareness of the European Group on Graves’ Orbitopathy (EUGOGO) Guidelines and Their Practical Usage in Croatia: An EUGOGO Pilot Study [PDF]
Acta Clinica CroaticaThis pilot study aimed to evaluate the awareness and practical usage of the European Group on Graves’ Orbitopathy (EUGOGO) Guidelines in Croatia, in view of a possible EUGOGO survey on a larger scale. A 27-question anonymous online questionnaire survey
Maja Baretić +2 more
exaly +5 more sources
Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy. [PDF]
European Thyroid JournalBackground: In 2021, the European Group on Graves’ orbitopathy (EUGOGO) published clinical practice guidelines for the management of GO, and in 2022, the American and European Thyroid Associations published the ATA/ETA consensus statement on the same ...
Maria Laura Tanda +2 more
exaly +5 more sources
Graves’ Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management [PDF]
Journal of Ophthalmology, 2015 Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder associated with thyroid disease which affects ocular and orbital tissues. GO follows a biphasic course in which an initial active phase of progression is followed by a subsequent partial ...
Alfonso L Sabater +2 more
exaly +5 more sources
Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London [PDF]
EyeThis is a summary of some of the panel and round table discussions held under the auspices of the European Group on Graves’ Orbitopathy (EUGOGO) GlobalTED Forum at Imperial College London in September 2025 to identify unmet needs, explore future ...
Mario Salvi, Vickie Lee, Colin M Dayan
exaly +4 more sources
Journal of Ophthalmology, 2021 Purpose. The intravenous glucocorticoid (iv GC) represents the mainstay of therapy for Graves’ ophthalmopathy (GO), but uncertainty remains concerning the optimal regimen.
Jing Chen, Nuo Xu, Huilan Sun, Gang Chen
doaj +2 more sources
The Clinical Features of Graves’ Orbitopathy with Elevated Intraocular Pressure
Journal of Ophthalmology, 2021 Background. To investigate the clinical characteristics of Graves’ orbitopathy (GO) with elevated intraocular pressure (IOP) using the European Group of Graves’ Orbitopathy (EUGOGO) system. Methods.
Shu-Xian Fan +8 more
doaj +2 more sources
A Korean Clinical Practice Framework for Thyroid Eye Disease: Integrating International Recommendations with Survey-Informed Consensus [PDF]
Endocrinology and MetabolismThyroid eye disease (TED), the most common extrathyroidal manifestation of Graves’ disease, requires individualized management that integrates medical, radiotherapeutic, and surgical interventions.
JaeSang Ko +7 more
doaj +2 more sources
Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients [PDF]
Frontiers in Endocrinology, 2019 Background: Quality of life (QoL) studies in patients with mild to moderate Graves' orbitopathy (GO) are scarce.Methods: The original GO-QoL questionnaire was translated to Portuguese and administered to 323 patients with Graves' disease.
Danilo Villagelin +8 more
doaj +3 more sources
Development and external validation of a nomogram for identifying patients with thyroid eye disease who screen positive for depressive symptoms: a two-center study [PDF]
Frontiers in EndocrinologyObjectiveTo identify factors independently associated with a positive depressive symptom screen in patients with thyroid eye disease (TED) and to develop and externally validate a nomogram-based model for individualized identification in a second-center ...
Shengzhi Jiao +6 more
doaj +2 more sources
Treatment of Graves' ophthalmopathy
Клиническая и экспериментальная тиреоидология, 2010 Graves' ophthalmopathy is one of most frequent extrathyroid manifestation of autoimmune thyroid diseases. In 3–5% cases it has severe progress and requires specific therapy.
doaj +2 more sources